secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001104659-23-052906
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccitech COO Chris Ellis announces retirement effective Oct 31, 2023
---------------------------------------------------------------------

- Chris Ellis, Chief Operating Officer (principal operating officer), informed company of retirement on April 24, 2023.
- Retirement effective October 31, 2023; no replacement named.
- Mr. Ellis's departure is a planned retirement, not an immediate resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923052906/0001104659-23-052906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465923052906/tm2313748d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-052906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer